Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.

Source:http://linkedlifedata.com/resource/pubmed/id/2426905

Download in:

View as

General Info

PMID
2426905